Efficacy and safety of viscosupplementation with hyaluronic acid for hip osteoarthritis: results from a cross-sectional study with a minimum follow-up of 4 years.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
30 12 2020
Historique:
received: 12 12 2020
accepted: 14 12 2020
entrez: 9 2 2021
pubmed: 10 2 2021
medline: 29 6 2021
Statut: epublish

Résumé

Osteoarthritis is the most common cause of disability in elderly. Hip osteoarthritis is the second most frequent form affecting a large joint and the social and economic impact on society of its related disability is expected to increase. The purpose of this study was to verify the efficacy and safety of ultrasound-guided viscosupplementation with high weight hyaluronic acid in hip osteoarthritis. 183 patients with painful hip OA (Kellgren-Lawrence 1-2-3) were treated from January 2014 to December 2016 with viscosupplementation. Patients were evaluated before injection (T0) and after 1,2,3,4 years through the VAS scale and Harris Hip Score (HHS). Patients who underwent to subsequent injections were followed and assessed. Subjects who underwent prosthesis were analyzed for a minimum of 6 months in order to detect any early postoperative complication. The mean improvement of HHS and VAS between T0 and T1 was statistically significant. Patients who underwent subsequent injections showed a higher improvement even if statistical significance was not observed. Results showed that patients with grade 2 of osteoarthritis had the higher change in the scores. No adverse effects were registered. No early complications were reported in those patients who needed prosthesis. Results observed confirm that ultrasound-guided viscosupplementation with high weight hyaluronic acid could be a possibility in the treatment of hip osteoarthritis, especially in patients with Kellgren-Lawrence grade 2 of disease. Subsequent injections are not characterized by similar positive effects. Outcomes of prosthetic surgery are not influenced by viscosupplementation.

Sections du résumé

BACKGROUND AND AIM OF THE WORK
Osteoarthritis is the most common cause of disability in elderly. Hip osteoarthritis is the second most frequent form affecting a large joint and the social and economic impact on society of its related disability is expected to increase. The purpose of this study was to verify the efficacy and safety of ultrasound-guided viscosupplementation with high weight hyaluronic acid in hip osteoarthritis.
METHODS
183 patients with painful hip OA (Kellgren-Lawrence 1-2-3) were treated from January 2014 to December 2016 with viscosupplementation. Patients were evaluated before injection (T0) and after 1,2,3,4 years through the VAS scale and Harris Hip Score (HHS). Patients who underwent to subsequent injections were followed and assessed. Subjects who underwent prosthesis were analyzed for a minimum of 6 months in order to detect any early postoperative complication.
RESULTS
The mean improvement of HHS and VAS between T0 and T1 was statistically significant. Patients who underwent subsequent injections showed a higher improvement even if statistical significance was not observed. Results showed that patients with grade 2 of osteoarthritis had the higher change in the scores. No adverse effects were registered. No early complications were reported in those patients who needed prosthesis.
DISCUSSION AND CONCLUSIONS
Results observed confirm that ultrasound-guided viscosupplementation with high weight hyaluronic acid could be a possibility in the treatment of hip osteoarthritis, especially in patients with Kellgren-Lawrence grade 2 of disease. Subsequent injections are not characterized by similar positive effects. Outcomes of prosthetic surgery are not influenced by viscosupplementation.

Identifiants

pubmed: 33559627
doi: 10.23750/abm.v91i14-S.11110
pmc: PMC7944698
doi:

Substances chimiques

Hyaluronic Acid 9004-61-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2020032

Références

Epidemiol Rev. 1988;10:1-28
pubmed: 3066625
Acta Biomed. 2019 Jan 10;90(1-S):104-109
pubmed: 30715007
Reumatismo. 2019 Sep 23;71(S1):5-21
pubmed: 31948191
Acta Biomed. 2016 Apr 15;87 Suppl 1:15-24
pubmed: 27104316
Br J Sports Med. 2021 Mar;55(5):256-261
pubmed: 32829298
Ann Rheum Dis. 2003 Dec;62(12):1145-55
pubmed: 14644851
Bone Joint J. 2016 Aug;98-B(8):1027-35
pubmed: 27482013
J Arthroplasty. 2016 Apr;31(4):820-3
pubmed: 26803711
Hip Int. 2018 Nov;28(2_suppl):66-72
pubmed: 30755117
J Orthop. 2020 Mar 25;21:137-149
pubmed: 32255995
Hip Int. 2019 May;29(3):303-309
pubmed: 29987953
Osteoarthritis Cartilage. 2011 Jun;19(6):611-9
pubmed: 21443958
J Shoulder Elbow Surg. 2015 Dec;24(12):1998-2007
pubmed: 26475638
Acta Biomed. 2019 Dec 05;90(12-S):174-177
pubmed: 31821304
Acta Biomed. 2016 Sep 13;87(2):148-55
pubmed: 27648996
Arthroscopy. 2020 May;36(5):1452-1464.e2
pubmed: 31919027
Ann Rheum Dis. 1999 Apr;58(4):201-7
pubmed: 10364897
Biorheology. 2007;44(2):59-74
pubmed: 17538199
J Bone Joint Surg Br. 2005 Apr;87(4):454-7
pubmed: 15795191
Arch Phys Med Rehabil. 2018 Mar;99(3):574-583.e1
pubmed: 28803906
Int Orthop. 2020 Jan;44(1):61-68
pubmed: 31020342
Osteoarthritis Cartilage. 2005 Mar;13(3):216-24
pubmed: 15727888
Acta Biomed. 2018 Nov 15;89(4):470-476
pubmed: 30657114
J Rheumatol Suppl. 1993 Aug;39:3-9
pubmed: 8410881
Med Sci Monit. 2019 Aug 27;25:6436-6445
pubmed: 31454342
Clin Orthop Relat Res. 2006 Oct;451:50-4
pubmed: 16906098
J Arthroplasty. 2015 Mar;30(3):507-11
pubmed: 25542833
Joint Bone Spine. 2002 Jun;69(4):388-91
pubmed: 12184436
Acta Biomed. 2014 Jan 23;84(3):212-8
pubmed: 24458166
Semin Arthritis Rheum. 2019 Feb;48(4):563-572
pubmed: 30072113
Arthritis Rheum. 2007 May;56(5):1397-407
pubmed: 17469096
Acta Vet Scand Suppl. 2003;98:127-40
pubmed: 15259786
Ann Rheum Dis. 2008 Oct;67(10):1406-11
pubmed: 18077540
Arthritis Res Ther. 2009;11(6):R183
pubmed: 20003205
Joint Bone Spine. 2006 Dec;73(6):705-9
pubmed: 16997602
Acta Biomed. 2016 Jul 28;87 Suppl 3:6-12
pubmed: 27467861
Clin Orthop Surg. 2020 Dec;12(4):521-528
pubmed: 33274030
Acta Radiol Diagn (Stockh). 1968;:Suppl 277:7-72
pubmed: 5706059
Arthritis Rheumatol. 2015 Jan;67(1):162-8
pubmed: 25250699
Acta Biomed. 2014 Sep 24;85 Suppl 2:52-8
pubmed: 25409719
J Am Acad Orthop Surg. 2013;21 Suppl 1:S1-6
pubmed: 23818185
Acta Biomed. 2018 Dec 18;90(1-S):67-74
pubmed: 30715001

Auteurs

Paolo Schiavi (P)

Orthopaedic Clinic, Department of Medicine and Surgery, University Hospital of Parma, Italy. ppschiav@gmail.com.

Filippo Calderazzi (F)

Orthopaedic Clinic, Department of Medicine and Surgery, University Hospital of Parma, Italy. fcalderazzi@ao.pr.it.

Martina Francesca Pedrini (MF)

Neuromotor Rehabilitation Unit, Figlie di San Camillo, Cremona, Italy. martipedrini@hotmail.com.

Fabrizio Tacci (F)

Orthopaedic Clinic, Department of Medicine and Surgery, University Hospital of Parma, Italy. ftacci@ao.pr.it.

Enrico Vaienti (E)

Orthopaedic Clinic, Department of Medicine and Surgery, University Hospital of Parma, Italy. enrico.vaienti@unipr.it.

Francesco Pogliacomi (F)

PARMA UNIVERSITY DEPARTMENT OF SURGICAL SCIENCES ORTHOPAEDIC AND TRAUMATOLOGY SECTION. fpogliacomi@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH